amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT Delayed Release Oral Capsule [Creon]
RxNorm concept 1373327, branded drug (sbd). Prescribable name: CREON 36,000 UNT / 180,000 UNT / 114,000 UNT Delayed Release Oral Capsule.
- RxCUI
- 1373327
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1373327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Creon (amylase 180,000 UNT / protease 114,000 UNT / lipase 36,000 UNT) Delayed Release Oral Capsule; Creon (amylases 180,000 UNT / endopeptidases 114,000 UNT / lipase 36,000 UNT) Delayed Release Oral Capsule
Related concepts
- amylase 180000 UNT (SCDC, consists of)
- protease 114000 UNT (SCDC, consists of)
- lipase 36000 UNT (SCDC, consists of)
- amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT [Creon] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Creon (BN, has ingredient)
- amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1373327 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1373327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1373327. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.